Dissemination of the Cardiovascular Risk Service

  • End date
    Aug 1, 2022
  • participants needed
  • sponsor
    Korey Kennelty
Updated on 25 January 2021
Korey Kennelty, PharmD
Primary Contact
Northeast Iowa Family Practice Center (1.5 mi away) Contact
+13 other location
systolic blood pressure


The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.


Cardiovascular disease (CVD) causes 2,200 deaths in Americans every day with one death every 39 seconds. Yet effective implementation of research-based interventions that reduce CVD-related illness and death remains a substantial challenge. The objective of this study is to test the scalability of a pharmacist-led, remote CVD risk and prevention services model in large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients, using a pragmatic cluster-randomized design. This service is called the Cardiovascular Risk Service (CVRS). There are limited data on the barriers and facilitators of implementation to enhance the CVRS in these types of diverse, complex health-systems. Therefore, scaling up our effective, innovative team-based intervention will require an assessment of barriers and facilitators to CVRS adoption, implementation, and maintenance. Our central hypothesis is that barriers and facilitators to CVRS implementation will vary across diverse primary care offices. We will use mixed methods including interviews, observations, and an innovative physician-pharmacist collaboration survey we developed to predict implementation of pharmacy-based services. The rationale for this proposed study is that overcoming barriers to implementation of a novel strategy to improve secondary prevention of CVD will lead to innovative strategies for broader adoption by health systems throughout the US.

Condition Diabetes Mellitus, Vascular Diseases, Hypertension, Diabetes Prevention, Diabetes and Hypertension, Diabetes Mellitus Types I and II, High Blood Pressure (Hypertension), High Blood Pressure (Hypertension - Pediatric), Diabetes (Pediatric), Elevated Blood Pressure, high blood pressure, arterial hypertension, diabetes mellitus (dm)
Treatment CVRS Intervention
Clinical Study IdentifierNCT03660631
SponsorKorey Kennelty
Last Modified on25 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Diabetes and Hypertension or Diabetes Mellitus Types I and II or Hypertension or Vascular Diseases or Diabetes (Pediatric) or Diabetes Mellitus or Hig...?
Do you have any of these conditions: High Blood Pressure (Hypertension - Pediatric) or Diabetes Prevention or Diabetes Mellitus or diabetes mellitus (dm) or High Blood Pressure (Hypertens...?
Clinical Staff Subjects
Must be a current clinic or pharmacy service employee who works as a provider, pharmacist, nurse, clerk or administrator
Patient Subjects
English or Spanish speaking
Seen in the clinic at least once in the previous 12 months
Currently has one of the following diseases
Diabetes with HA1c 9.0% or greater and/or
Hypertension (uncomplicated) with systolic blood pressure 150 mm Hg or greater
Informal Caregiver Subjects
Person identified by the patient subject who assists the patient subject with activities of daily living or other aspects of the patient subject's healthcare

Exclusion Criteria

Study wide exclusions
Inability to give consent
Nursing home residence
No telephone
Additional patient subject exclusions
Cancer with a life expectancy less than 24 months
Diagnosis of dementia
Plans to terminate care from the clinic within 24 months
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note